Reimbursed medication adherence enhancing interventions in 12 european countries: Current state of the art and future challenges.

Background: Medication non-adherence jeopardises the effectiveness of chronic therapies and negatively affects financial sustainability of healthcare systems. Available medication adherence-enhancing interventions (MAEIs) are utilised infrequently, and even more rarely reimbursed. The aim of this pa...

Descripción completa

Detalles Bibliográficos
Autores: Kardas, Przemysław, Bago, Martina, Barnestein-Fonseca, Pilar, Garuolienė, Kristina, Granas, Anne Gerd, Gregório, João, Hadžiabdić, Maja Ortner, Kostalova, Barbora, Leiva-Fernández, Francisca, Lewek, Pawel, Mala-Ladova, Katerina, Schneider, Marie Paule, van Boven, Job F M, Volmer, Daisy, Ziampara, Ioli, Ágh, Tamás
Tipo de recurso: artículo
Fecha de publicación:2022
País:España
Institución:Instituto de Salud Carlos III (ISCIII)
Repositorio:Repisalud
Idioma:inglés
OAI Identifier:oai:repisalud.isciii.es:20.500.12105/18736
Acceso en línea:http://hdl.handle.net/20.500.12105/18736
Access Level:acceso abierto
Palabra clave:Europe
drugs
healthcare systems
interventions
medication adherence
non-adherence
persistence
reimbursement
id ES_f0152e654cb58c812a15a3faa2d28fbc
oai_identifier_str oai:repisalud.isciii.es:20.500.12105/18736
network_acronym_str ES
network_name_str España
repository_id_str
spelling Reimbursed medication adherence enhancing interventions in 12 european countries: Current state of the art and future challenges.Kardas, PrzemysławBago, MartinaBarnestein-Fonseca, PilarGaruolienė, KristinaGranas, Anne GerdGregório, JoãoHadžiabdić, Maja OrtnerKostalova, BarboraLeiva-Fernández, FranciscaLewek, PawelMala-Ladova, KaterinaSchneider, Marie Paulevan Boven, Job F MVolmer, DaisyZiampara, IoliÁgh, TamásEuropedrugshealthcare systemsinterventionsmedication adherencenon-adherencepersistencereimbursementBackground: Medication non-adherence jeopardises the effectiveness of chronic therapies and negatively affects financial sustainability of healthcare systems. Available medication adherence-enhancing interventions (MAEIs) are utilised infrequently, and even more rarely reimbursed. The aim of this paper was to review reimbursed MAEIs across selected European countries. Methods: Data on reimbursed MAEIs were collected from European countries at the ENABLE Cost Action expert meeting in September 2021. The identified MAEIs were analysed and clustered according to their characteristics, direct vs. indirect relation to adherence, and the targeted adherence phase. Results: Out of 12 contributing countries, 10 reported reimbursed MAEIs, 28 in total, of which 20 were identified as MAEIs targeting adherence directly. Reimbursed MAEIs were most often performed by either doctors (n = 6), nurses (n = 6), or pharmacists (n = 3). The most common types of MAEIs were education (n = 6), medication regimen management (n = 5), and adherence monitoring feedback (n = 4). Only seven reimbursed MAEIs were technology-mediated, whereas 11 addressed two interlinked phases of medication adherence, i.e., implementation and persistence. Conclusion: Our review highlights the scarcity of reimbursed MAEIs across the selected European countries, and calls for their more frequent use and reimbursement.20242024-02-2720222022-08-1120222022-08-11research articlehttp://purl.org/coar/resource_type/c_2df8fbb1VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articlehttp://hdl.handle.net/20.500.12105/18736reponame:Repisaludinstname:Instituto de Salud Carlos III (ISCIII)Inglésengopen accesshttp://purl.org/coar/access_right/c_abf2Attribution 4.0 Internationalhttp://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:repisalud.isciii.es:20.500.12105/187362026-06-12T12:43:37Z
dc.title.none.fl_str_mv Reimbursed medication adherence enhancing interventions in 12 european countries: Current state of the art and future challenges.
title Reimbursed medication adherence enhancing interventions in 12 european countries: Current state of the art and future challenges.
spellingShingle Reimbursed medication adherence enhancing interventions in 12 european countries: Current state of the art and future challenges.
Kardas, Przemysław
Europe
drugs
healthcare systems
interventions
medication adherence
non-adherence
persistence
reimbursement
title_short Reimbursed medication adherence enhancing interventions in 12 european countries: Current state of the art and future challenges.
title_full Reimbursed medication adherence enhancing interventions in 12 european countries: Current state of the art and future challenges.
title_fullStr Reimbursed medication adherence enhancing interventions in 12 european countries: Current state of the art and future challenges.
title_full_unstemmed Reimbursed medication adherence enhancing interventions in 12 european countries: Current state of the art and future challenges.
title_sort Reimbursed medication adherence enhancing interventions in 12 european countries: Current state of the art and future challenges.
dc.creator.none.fl_str_mv Kardas, Przemysław
Bago, Martina
Barnestein-Fonseca, Pilar
Garuolienė, Kristina
Granas, Anne Gerd
Gregório, João
Hadžiabdić, Maja Ortner
Kostalova, Barbora
Leiva-Fernández, Francisca
Lewek, Pawel
Mala-Ladova, Katerina
Schneider, Marie Paule
van Boven, Job F M
Volmer, Daisy
Ziampara, Ioli
Ágh, Tamás
author Kardas, Przemysław
author_facet Kardas, Przemysław
Bago, Martina
Barnestein-Fonseca, Pilar
Garuolienė, Kristina
Granas, Anne Gerd
Gregório, João
Hadžiabdić, Maja Ortner
Kostalova, Barbora
Leiva-Fernández, Francisca
Lewek, Pawel
Mala-Ladova, Katerina
Schneider, Marie Paule
van Boven, Job F M
Volmer, Daisy
Ziampara, Ioli
Ágh, Tamás
author_role author
author2 Bago, Martina
Barnestein-Fonseca, Pilar
Garuolienė, Kristina
Granas, Anne Gerd
Gregório, João
Hadžiabdić, Maja Ortner
Kostalova, Barbora
Leiva-Fernández, Francisca
Lewek, Pawel
Mala-Ladova, Katerina
Schneider, Marie Paule
van Boven, Job F M
Volmer, Daisy
Ziampara, Ioli
Ágh, Tamás
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv
dc.subject.none.fl_str_mv Europe
drugs
healthcare systems
interventions
medication adherence
non-adherence
persistence
reimbursement
topic Europe
drugs
healthcare systems
interventions
medication adherence
non-adherence
persistence
reimbursement
description Background: Medication non-adherence jeopardises the effectiveness of chronic therapies and negatively affects financial sustainability of healthcare systems. Available medication adherence-enhancing interventions (MAEIs) are utilised infrequently, and even more rarely reimbursed. The aim of this paper was to review reimbursed MAEIs across selected European countries. Methods: Data on reimbursed MAEIs were collected from European countries at the ENABLE Cost Action expert meeting in September 2021. The identified MAEIs were analysed and clustered according to their characteristics, direct vs. indirect relation to adherence, and the targeted adherence phase. Results: Out of 12 contributing countries, 10 reported reimbursed MAEIs, 28 in total, of which 20 were identified as MAEIs targeting adherence directly. Reimbursed MAEIs were most often performed by either doctors (n = 6), nurses (n = 6), or pharmacists (n = 3). The most common types of MAEIs were education (n = 6), medication regimen management (n = 5), and adherence monitoring feedback (n = 4). Only seven reimbursed MAEIs were technology-mediated, whereas 11 addressed two interlinked phases of medication adherence, i.e., implementation and persistence. Conclusion: Our review highlights the scarcity of reimbursed MAEIs across the selected European countries, and calls for their more frequent use and reimbursement.
publishDate 2022
dc.date.none.fl_str_mv 2022
2022-08-11
2022
2022-08-11
2024
2024-02-27
dc.type.none.fl_str_mv research article
http://purl.org/coar/resource_type/c_2df8fbb1
VoR
http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv http://hdl.handle.net/20.500.12105/18736
url http://hdl.handle.net/20.500.12105/18736
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
Attribution 4.0 International
http://creativecommons.org/licenses/by/4.0/
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
Attribution 4.0 International
http://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
dc.source.none.fl_str_mv reponame:Repisalud
instname:Instituto de Salud Carlos III (ISCIII)
instname_str Instituto de Salud Carlos III (ISCIII)
reponame_str Repisalud
collection Repisalud
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869423923994558464
score 15.81155

Similares en LA Referencia